{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "Matthew Goldstein and David Chen contributed reporting.", "original": "By JULIE CRESWELL, STEPHANIE CLIFFORD and ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Julie", "organization": "", "lastname": "CRESWELL"}, {"rank": 2, "role": "reported", "firstname": "Stephanie", "organization": "", "lastname": "CLIFFORD"}, {"rank": 3, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Federal Bureau of Investigation arrests Turing Pharmaceuticals head Martin Shkreli, who has been vilified for drug price-gouging, on securities fraud and wire fraud charges relating to his work at hedge fund MSMB Capital Management and biopharmaceutical company Retrophin; critics assert arrest is comeuppance for brash chief executive officer.", "type_of_material": "News", "word_count": "1356", "lead_paragraph": "The entrepreneur, who has been criticized for price gouging on drugs, faces securities fraud charges related to his work at MSMB Capital Management and Retrophin.", "pub_date": "2015-12-18T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Drug C.E.O. Martin Shkreli Arrested on Fraud Charges", "print_headline": "F.B.I. Arrests C.E.O. Vilified for Drug Costs"}, "snippet": "The entrepreneur, who has been criticized for price gouging on drugs, faces securities fraud charges related to his work at MSMB Capital Management and Retrophin.", "multimedia": [{"height": 126, "url": "images/2015/12/18/business/18shkreli-web4/18shkreli-web4-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/18/business/18shkreli-web4/18shkreli-web4-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 402, "url": "images/2015/12/18/business/18shkreli-web4/18shkreli-web4-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "402", "xlarge": "images/2015/12/18/business/18shkreli-web4/18shkreli-web4-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/18/business/18shkreli-web4/18shkreli-web4-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/18/business/18shkreli-web4/18shkreli-web4-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/18/business/shkreli-fraud-charges.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "MSMB Capital Management LLC", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Retrophin Inc", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Securities and Commodities Violations", "name": "subject"}, {"rank": "6", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "7", "is_major": "Y", "value": "Federal Bureau of Investigation", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Hedge Funds", "name": "subject"}], "blog": [], "_id": "5672b86f38f0d82eed76c633", "source": "The New York Times"}